Cello Health BioConsulting will be attending these upcoming events:

Webinar: The Bold New Player in Cancer: How Chinese Biotechs Are Fueling the Oncology Space

Date: December 2, 2019

Time: 10:00 AM EST


  • James T. Lee, PhD, Associate Principal, Defined Health, a Cello Health Business


  • Brad Loncar, Chief Executive Officer, Loncar Investments LLC
  • Guillaume Vignon, PhD, Senior Vice President, Business Development, BeiGene
  • Weimin Tang, PhD, Global Business Head and Executive VP, I-Mab BioPharma

Webinar: The Biotech’s Conundrum in Immuno-Oncology: Weighing Hot Versus Cold Tumors, CPI-Naïve Versus CPI-Experienced Patients

Date: December 4, 2019

Time: 11:30 AM EST


  • Jeff Bockman, PhD, EVP, Oncology Practice, Defined Health, a Cello Health Business


  • Mike Curran, PhD, Associate Professor, Immunology, MD Anderson
  • Emmett Schimdt, MD, Associate Vice President, Merck
  • Vanessa Lucey, PhD, Director, CRI Venture Fund and Clinical Accelerator
    Cancer Research Institute
  • Louis Kayitalire, MD, CMO, F-Star Biotechnology
  • Steve Worland, PhD, President and CEO, eFFECTOR Therapeutics


December 7, 2019 - December 12, 2019

Location: Orlando, FL